I. Alymova

Most-cited papers

1. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.

   E. Govorkova, S. Kodihalli, I. Alymova, B. Fanget +1 more

   1999Developments in biological standardization83 citations

   Semantic Scholar

   Save

2. Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo

   I. Alymova, G. Taylor, T. Takimoto, Tsu-Hsing Lin +5 more

   2004Antimicrobial Agents and Chemotherapy79 citations Open access

   Semantic Scholar

   Save

3. Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82

   I. Alymova, Amanda M. Green, N. C. van de Velde, J. McAuley +3 more

   2011Journal of Virology75 citations Open access

   Semantic Scholar

   Save

4. Evolution and Virulence of Influenza A Virus Protein PB1-F2

   R. Kamal, I. Alymova, I. York

   2017International Journal of Molecular Sciences67 citations Open access

   Semantic Scholar

   Save

5. Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites.

   Yanming An, J. Mccullers, I. Alymova, L. Parsons +1 more

   2015Journal of Proteome Research62 citations

   Semantic Scholar

   Save

6. Influenza virus N-linked glycosylation and innate immunity

   I. York, J. Stevens, I. Alymova

   2018Bioscience Reports60 citations Open access

   Semantic Scholar

   Save

7. Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence

   I. Alymova, I. York, G. Air, J. Cipollo +6 more

   2016Scientific Reports59 citations Open access

   Semantic Scholar

   Save

8. A Novel Cytotoxic Sequence Contributes to Influenza A Viral Protein PB1-F2 Pathogenicity and Predisposition to Secondary Bacterial Infection

   I. Alymova, A. Samarasinghe, P. Vogel, Amanda M. Green +2 more

   2013Journal of Virology51 citations Open access

   Semantic Scholar

   Save

9. Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents.

   M. Burstein, A. Serbin, T. V. Khakhulina, I. Alymova +6 more

   1999Antiviral Research50 citations

   Semantic Scholar

   Save

10. The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae

    I. Alymova, A. Portner, T. Takimoto, K. Boyd +2 more

    2005Antimicrobial Agents and Chemotherapy49 citations Open access

    Semantic Scholar

    Save

11. Immunogenicity and Protective Efficacy in Mice of Influenza B Virus Vaccines Grown in Mammalian Cells or Embryonated Chicken Eggs

    I. Alymova, S. Kodihalli, E. Govorkova, B. Fanget +2 more

    1998Journal of Virology46 citations Open access

    Semantic Scholar

    Save

12. Neuraminidase inhibitors as antiviral agents.

    I. Alymova, G. Taylor, A. Portner

    2005Current Drug Targets - Infectious Disorders33 citations

    Semantic Scholar

    Save

13. N-Linked Glycan at Residue 523 of Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Masks a Second Receptor-Binding Site

    V. Mishin, Makiko Watanabe, G. Taylor, J. DeVincenzo +3 more

    2010Journal of Virology29 citations Open access

    Semantic Scholar

    Save

14. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.

    I. Alymova, A. Portner, V. Mishin, J. Mccullers +2 more

    2012Glycobiology28 citations Open access

    Semantic Scholar

    Save

15. Effect of Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 on Growth and Pathogenicity of Sendai/Human Parainfluenza Type 3 Chimera Virus in Mice

    Makiko Watanabe, V. Mishin, Scott A. Brown, C. Russell +7 more

    2009Antimicrobial Agents and Chemotherapy28 citations Open access

    Semantic Scholar

    Save

16. Efficacy of the Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 in Mice—Further Evaluation

    I. Alymova, Makiko Watanabe, K. Boyd, P. Chand +2 more

    2009Antiviral Therapy25 citations Open access

    Semantic Scholar

    Save

17. Loss of the N-Linked Glycan at Residue 173 of Human Parainfluenza Virus Type 1 Hemagglutinin-Neuraminidase Exposes a Second Receptor-Binding Site

    I. Alymova, G. Taylor, V. Mishin, Makiko Watanabe +5 more

    2008Journal of Virology23 citations Open access

    Semantic Scholar

    Save

18. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome

    I. Alymova, J. Cipollo, L. Parsons, Nedzad Music +9 more

    2022mBio19 citations Open access

    Semantic Scholar

    Save

19. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus

    C. Ryan, V. Zaitsev, D. Tindal, J. C. Dyason +5 more

    2006Glycoconjugate Journal19 citations

    Semantic Scholar

    Save

20. Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses

    I. Alymova, J. Mccullers, R. Kamal, P. Vogel +3 more

    2018Scientific Reports14 citations Open access

    Semantic Scholar

    Save

21. A Recombinant Sendai Virus Is Controlled by CD4+ Effector T Cells Responding to a Secreted Human Immunodeficiency Virus Type 1 Envelope Glycoprotein

    Scott A. Brown, J. Hurwitz, A. Zirkel, S. Surman +6 more

    2007Journal of Virology13 citations Open access

    Semantic Scholar

    Save

22. Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers

    I. Alymova, I. York, J. Mccullers

    2014PLoS ONE11 citations Open access

    Semantic Scholar

    Save

23. Development of Novel Selective Parainfluenza Virus Hemagglutinin–Neuraminidase Inhibitors

    I. Alymova, Makiko Watanabe, V. Mishin, Y. Babu +1 more

    20082 citations

    Semantic Scholar

    Save

24. Influenza A virus N-linked glycosylation sites with very low glycan occupancy: identification, evolutionary dynamics, and impact on virus biology

    I. Alymova, Wen-Pin Tzeng, Alexander S. Jureka, John R. Barr +4 more

    2025International Journal of Infectious Diseases1 citations Open access

    Semantic Scholar

    Save

25. The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae

    I. Alymova, A. Portner, T. Takimoto, K. Boyd +2 more

    20041 citations

    Semantic Scholar

    Save

26. N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population

    I. Alymova, Betlehem Mekonnen, Dong-Xia Wang, R. Kamal +5 more

    2026Journal of Virology0 citations Open access

    Semantic Scholar

    Save

27. GLYCOSYLATION SITE OCCUPANCY OF THE HEMAGGLUTININ GLOBULAR HEAD IS IMPLICATED IN THE IMMUNE RESPONSE TO INFLUENZA A VIRUS

    I. Alymova, J. Cipollo, Yanming An, R. Kamal +3 more

    2020Journal of Immunology0 citations

    Semantic Scholar

    Save

28. N‐linked glycosylation of Hemagglutinin Globular Head Modulates the Antibody Response to H3N2 Influenza A Virus

    I. Alymova

    2016The FASEB Journal0 citations

    Semantic Scholar

    Save

29. Eggs Mammalian Cells or Embryonated Chicken of Influenza B Virus Vaccines Grown in Immunogenicity and Protective Efficacy in Mice

    I. Alymova, S. Kodihalli, E. Govorkova, B. Fanget +2 more

    19970 citations

    Semantic Scholar

    Save